Paul Tudor Jones Bristol Myers Squibb CO Transaction History

Tudor Investment Corp Et Al

$15.5 Billion
Q1 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 290,600 shares of BMY stock, worth $12.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

290,600

Previous 767,451 62.13%

Holding current value

$12.1 Million

Previous $39.4 Million 59.98%

% of portfolio

0.1%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $37.2 Million - $44.4 Million	767,451 New	767,451 $39.4 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.04 Million - $1.15 Million	16,254 Added 144.66%	27,490 $1.76 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $17.5 Million - $19.9 Million	-266,633 Reduced 95.96%	11,236 $779,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $137 Million - $162 Million	-1,997,667 Reduced 87.79%	277,869 $20 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $539 - $318,886	-4,150 Reduced 0.18%	2,275,536 $4.95 Million

Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $165 Million - $182 Million	2,270,877 Added 25779.06%	2,279,686 $4.88 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $9.98 Million - $11.6 Million	-186,135 Reduced 95.48%	8,809 $549,000
Q3 2021 Nov 17, 2021	SELL	$59.17 - $69.31 $134 Million - $157 Million	-2,264,818 Reduced 92.07%	194,944 $11.5 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $146 Million - $170 Million	2,459,762 New	2,459,762 $14.6 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $3.61 Million - $3.93 Million	-58,232 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2.42 Million - $2.72 Million	-40,784 Reduced 41.19%	58,232 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $577,169 - $654,038	9,996 Added 11.23%	99,016 $6.14 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $7.67 Million - $8.48 Million	-171,836 Reduced 65.87%	89,020 $4.04 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $9.07 Million - $10.8 Million	201,011 Added 335.89%	260,856 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $3.99 Million - $5.18 Million	-81,904 Reduced 57.78%	59,845 $3.11 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $3.04 Million - $3.43 Million	55,031 Added 63.46%	141,749 $8.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $916,765 - $1.14 Million	18,143 Added 26.46%	86,718 $4.8 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $2.32 Million - $2.68 Million	38,789 Added 130.23%	68,575 $4.34 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $5.7 Million - $6.22 Million	-95,178 Reduced 76.16%	29,786 $1.83 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $6.9 Million - $7.97 Million	124,964	124,964 $7.97 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account